Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …

Parkinson's disease (PD) and atypical Parkinsonian syndromes are progressive
heterogeneous neurodegenerative diseases that share clinical characteristic of …

Multiple system atrophy (MSA) is an orphan, fatal, adult-onset neurodegenerative disorder of
uncertain etiology that is clinically characterized by various combinations of parkinsonism …

Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders,
particularly in the early stages of the disease. An autonomic-only presentation can be …

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterised
by a variable combination of autonomic failure, levodopa-unresponsive parkinsonism …

Objective To analyze changes in cerebral grey matter volume and white matter density in
non-dementia Parkinson's disease patients using voxel-based morphometry (VBM) …

Recent post-mortem studies reported 22–37% of patients with multiple system atrophy can
develop cognitive impairment. With the aim of identifying associations between cognitive …

Objective Cognitive impairment in multiple system atrophy (MSA) is common, but remain
poorly characterized. We evaluated cognitive and behavioral features in MSA patients and …

Multiple system atrophy (MSA) is an adult-onset, progressive neurodegenerative disorder.
Patients with MSA show various phenotypes during the course of their illness, including …